Which is safer: SUNPHARMA.NS or TAP?
Safety has three computed layers here: business quality (SUNPHARMA.NS —/100 vs TAP 100/100), signal maturity (235 vs 30 bars), and your position sizing — which only you control. We publish the pieces and the method, not a single verdict.
| Snapshot | 2026-09-01 · source: yahoo-direct | |
|---|---|---|
| SUNPHARMA.NS (Sun Pharmaceutical) | TAP (Molson Coors) | |
| Market / sector | in · Pharma | us · Consumer Staples |
| Price | ₹1,913 | $41.66 |
| Quality score | —/100 | 100/100 |
| Engine signal | LONG · 235 bars · uPnL +16.0% | LONG · 30 bars · uPnL -0.3% |
| Total return | +8.4% | -18.5% |
Cite this page
Balance Labs Research Desk (2026-09-01). "Which is safer: SUNPHARMA.NS or TAP?." balancelabs.app · https://balancelabs.app/stocks/compare/sunpharma.ns-vs-tap/q/sunpharma.ns-or-tap-safer · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← SUNPHARMA.NS vs TAP · snapshot 2026-09-01 · not investment advice